FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.1  |  FHIR Version n/a  User: [n/a]

34697211000001106: Ethinylestradiol 30microgram / Drospirenone 3mg tablets 21 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 16-Aug 2017. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
104842001000001113 Ethinylestradiol 30microgram / Drospirenone 3mg tablets 21 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
104842101000001114 Ethinylestradiol 30microgram / Drospirenone 3mg tablets 21 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ethinylestradiol 30microgram / Drospirenone 3mg tablets 21 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Ethinylestradiol 30microgram / Drospirenone 3mg tablets 21 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Ethinylestradiol 30microgram / Drospirenone 3mg tablets 21 tablet Has VMP Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Ethinylestradiol 30microgram / Drospirenone 3mg tablets 21 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Ethinylestradiol 30microgram / Drospirenone 3mg tablets 21 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Ethinylestradiol 30microgram / Drospirenone 3mg tablets 21 tablet Has specific active ingredient Drospirenone true Inferred relationship Existential restriction modifier
Ethinylestradiol 30microgram / Drospirenone 3mg tablets 21 tablet Has specific active ingredient Ethinylestradiol true Inferred relationship Existential restriction modifier
Ethinylestradiol 30microgram / Drospirenone 3mg tablets 21 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Ellanite 0.03mg/3mg tablets (Kent Pharma (UK) Ltd) 21 tablet Is a True Ethinylestradiol 30microgram / Drospirenone 3mg tablets 21 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start